<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37652474</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1791-7549</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>In vivo (Athens, Greece)</Title><ISOAbbreviation>In Vivo</ISOAbbreviation></Journal><ArticleTitle>Assessing the Risk of Stroke in the Elderly in the Context of Long-COVID, Followed Through the Lens of Family Medicine.</ArticleTitle><Pagination><StartPage>2284</StartPage><EndPage>2295</EndPage><MedlinePgn>2284-2295</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21873/invivo.13331</ELocationID><Abstract><AbstractText Label="BACKGROUND/AIM" NlmCategory="OBJECTIVE">Patients infected with COVID-19 may experience a range of acute and chronic neurological disorders. While severe neurological complications like strokes and seizures were less common during the acute or post-COVID period, the long-term effects of COVID-19, known as long COVID, have received limited attention. This study aimed to examine the lasting consequences of SARS-CoV-2 infection and establish potential connections with related diseases.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">We followed a group of 157 patients for one year, predominantly from urban areas (61.8%), divided into three groups based on the presence of associated diseases that pose health risks: the control (43 patients), low-risk (67 patients), and high-risk (47 patients) groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We observed an inverse relationship between oxygen saturation and erythrocyte sedimentation rate, as well as a direct relationship between varicose disease and dyslipidemia, and gastrointestinal disease. Additionally, we noticed a less significant improvement in oxygen saturation and increased prevalence of psychoanxiety disorders in individuals undergoing anticoagulant treatment.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The impact of long COVID and its secondary effects, which persist for an extended period and are influenced by associated diseases, can be effectively monitored and addressed by primary care physicians. These findings can serve as a basis for developing more efficient approaches to managing the long-term consequences of COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moldovan</LastName><ForeName>Andrada Florina</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Pharmacy, Doctoral School, University of Oradea, Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moga</LastName><ForeName>Ioana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Pharmacy, Medicine Department, University of Oradea, Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moga</LastName><ForeName>Titus</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Pharmacy, Medicine Department, University of Oradea, Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghitea</LastName><ForeName>Evelin Claudia</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Pharmacy, University of Oradea, Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babes</LastName><ForeName>Katalin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Pharmacy, Medicine Department, University of Oradea, Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghitea</LastName><ForeName>Timea Claudia</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Pharmacy, Department of Pharmacy, University of Oradea, Oradea, Romania timea.ghitea@csud.uoradea.ro.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>In Vivo</MedlineTA><NlmUniqueID>8806809</NlmUniqueID><ISSNLinking>0258-851X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005194" MajorTopicYN="N">Family Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012640" MajorTopicYN="N">Seizures</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">elderly people</Keyword><Keyword MajorTopicYN="N">stroke</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList><CoiStatement>The Authors declare no conflicts of interest in relation to this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>20</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37652474</ArticleId><ArticleId IdType="pmc">PMC10500484</ArticleId><ArticleId IdType="doi">10.21873/invivo.13331</ArticleId><ArticleId IdType="pii">37/5/2284</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Balcom E, Nath A, Power C. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease. Brain. 2021;144(12):3576&#x2013;3588. doi: 10.1093/brain/awab302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab302</ArticleId><ArticleId IdType="pmc">PMC8719840</ArticleId><ArticleId IdType="pubmed">34398188</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Turrent-Carriles A, Herrera-F&#xe9;lix J, Amigo M. Renal involvement in antiphospholipid syndrome. Front Immunol. 2018;9:1008. doi: 10.3389/fimmu.2018.01008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01008</ArticleId><ArticleId IdType="pmc">PMC5966534</ArticleId><ArticleId IdType="pubmed">29867982</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamashta MA. San Diego, CA, USA, Academic Press. 2011. Chapter 53 - clinical presentation of antiphospholipid syndrome. In: Systemic lupus erythematosus (fifth edition). Lahita RG (ed.) pp. pp. 1001&#x2013;1014.</Citation></Reference><Reference><Citation>Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener H, Heidbuchel H, Hendriks J, Hindricks G, Manolis A, Oldgren J, Popescu B, Schotten U, Van Putte B, Vardas P, ESC Scientific Document Group 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with eacts. Eur J Cardiothorac Surg. 2016;50(5):1&#x2013;88. doi: 10.1093/eurheartj/ehw210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw210</ArticleId><ArticleId IdType="pubmed">27663299</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly S, Eikelboom J, Dorian P, Hohnloser S, Gretler D, Sinha U, Ezekowitz M. Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa) Eur Heart J. 2013;34(20):1498&#x2013;1505. doi: 10.1093/eurheartj/eht039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht039</ArticleId><ArticleId IdType="pmc">PMC3659305</ArticleId><ArticleId IdType="pubmed">23487517</ArticleId></ArticleIdList></Reference><Reference><Citation>Laslo C, Stoian A, Socea B, Paduraru D, Bodean O, Socea L, Neagu T, Stanescu A, Marcu D, Diaconu C. New oral anticoagulants and their reversal agents. J Mind Med Sci. 2018;5(2):195&#x2013;201. doi: 10.22543/7674.52.P195201.</Citation><ArticleIdList><ArticleId IdType="doi">10.22543/7674.52.P195201</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart R, Pearce L, Aguilar M. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857. doi: 10.7326/0003-4819-146-12-200706190-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-146-12-200706190-00007</ArticleId><ArticleId IdType="pubmed">17577005</ArticleId></ArticleIdList></Reference><Reference><Citation>Friberg L, Skeppholm M, Ter&#xe9;nt A. Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1. J Am Coll Cardiol. 2015;65(3):225&#x2013;232. doi: 10.1016/j.jacc.2014.10.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2014.10.052</ArticleId><ArticleId IdType="pubmed">25614418</ArticleId></ArticleIdList></Reference><Reference><Citation>Mant J, Hobbs F, Fletcher K, Roalfe A, Fitzmaurice D, Lip G, Murray E. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet. 2007;370(9586):493&#x2013;503. doi: 10.1016/S0140-6736(07)61233-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61233-1</ArticleId><ArticleId IdType="pubmed">17693178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamberts M, Lip G, Hansen M, Lindhardsen J, Olesen J, Rauns&#xf8; J, Olsen A, Andersen P, Gerds T, Fosb&#xf8;l E, Torp-Pedersen C, Gislason G. Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy. Ann Int Med. 2014;161(10):690. doi: 10.7326/M13-1581.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M13-1581</ArticleId><ArticleId IdType="pubmed">25402512</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas K, Douglas V, Moschos M. Ocular manifestations of COVID-19 (SARS-CoV-2): a critical review of current literature. In Vivo. 2020;34(3 suppl):1619&#x2013;1628. doi: 10.21873/invivo.11952.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.11952</ArticleId><ArticleId IdType="pmc">PMC8378034</ArticleId><ArticleId IdType="pubmed">32503820</ArticleId></ArticleIdList></Reference><Reference><Citation>Malczyk E, Dzi&#x119;gielewska-G&#x119;siak S, Fatyga E, Zi&#xf3;&#x142;ko E, Kokot T, Muc-Wierzgon M. Body composition in healthy older persons: Role of the ratio of extracellular/total body water. J Biol Regul Homeost Agents. 2016;30(3):767&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pubmed">27655495</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanita.eu. Available at: https://tanita.eu/media/pdf/productstanita/professional/MC-780/MC-780MA%20N%20Instruction%20Manual%20%28EN%29%202018%20%282%29.pdf. [Last accessed on March 28, 2023]</Citation></Reference><Reference><Citation>Salemi P, Skalamera Olson J, Dickson L, Germain-Lee E. Ossifications in albright hereditary osteodystrophy: Role of genotype, inheritance, sex, age, hormonal status, and BMI. J Clin Endocrinol Metab. 2018;103(1):158&#x2013;168. doi: 10.1210/jc.2017-00860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2017-00860</ArticleId><ArticleId IdType="pmc">PMC5761497</ArticleId><ArticleId IdType="pubmed">29059381</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hove R, Brohet R, Van Royen B, Nolte P. High correlation of the Oxford Knee Score with postoperative pain, but not with performance-based functioning. Knee Surgery, Sports Traumatology, Arthrosc. 2016;24(10):3369&#x2013;3375. doi: 10.1007/s00167-015-3585-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-015-3585-9</ArticleId><ArticleId IdType="pubmed">25820654</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghitea T. The influence of diet therapeutic intervention on the sarcopenic index of patients with metabolic syndrome. Acta Endocrinol (Bucharest) 2020;16(4):470&#x2013;478. doi: 10.4183/aeb.2020.470.</Citation><ArticleIdList><ArticleId IdType="doi">10.4183/aeb.2020.470</ArticleId><ArticleId IdType="pmc">PMC8126402</ArticleId><ArticleId IdType="pubmed">34084239</ArticleId></ArticleIdList></Reference><Reference><Citation>Nistor-Cseppento C, Gherle A, Negrut N, Bungau S, Sabau A, Radu A, Bungau A, Tit D, Uivaraseanu B, Ghitea T, Uivarosan D. The outcomes of robotic rehabilitation assisted devices following spinal cord injury and the prevention of secondary associated complications. Medicina. 2022;58(10):1447. doi: 10.3390/medicina58101447.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58101447</ArticleId><ArticleId IdType="pmc">PMC9611825</ArticleId><ArticleId IdType="pubmed">36295607</ArticleId></ArticleIdList></Reference><Reference><Citation>Popa A, Fratila O, Rus M, Aron R, Vesa C, Pantis C, Diaconu C, Bratu O, Bungau S, Nemeth S. Risk factors for adiposity in the urban population and influence on the prevalence of overweight and obesity. Exp Ther Med. 2020;20(1):129&#x2013;133. doi: 10.3892/etm.2020.8662.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2020.8662</ArticleId><ArticleId IdType="pmc">PMC7271696</ArticleId><ArticleId IdType="pubmed">32509005</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchernof A, Despr&#xe9;s J. Pathophysiology of human visceral obesity: an update. Physiological Rev. 2013;93(1):359&#x2013;404. doi: 10.1152/physrev.00033.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00033.2011</ArticleId><ArticleId IdType="pubmed">23303913</ArticleId></ArticleIdList></Reference><Reference><Citation>Despr&#xe9;s J, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rod&#xe9;s-Cabau J, Bertrand O, Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039&#x2013;1049. doi: 10.1161/atvbaha.107.159228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/atvbaha.107.159228</ArticleId><ArticleId IdType="pubmed">18356555</ArticleId></ArticleIdList></Reference><Reference><Citation>Alalwan T. Phenotypes of sarcopenic obesity: exploring the effects on peri-muscular fat, the obesity paradox, hormone-related responses and the clinical implications. Geriatrics. 2020;5(1):8. doi: 10.3390/geriatrics5010008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/geriatrics5010008</ArticleId><ArticleId IdType="pmc">PMC7151126</ArticleId><ArticleId IdType="pubmed">32075166</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli C, Jones S, Yang J, Rajagopalan H, O&#x2019;Donnell L, Chernyak Y, Tobin K, Cerfolio R, Francois F, Horwitz L. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. doi: 10.1136/bmj.m1966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1966</ArticleId><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Lei J, Li Z, Yan L. Potential Effects of coronaviruses on the liver: an update. Front Med. 2021;8:651658. doi: 10.3389/fmed.2021.651658.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.651658</ArticleId><ArticleId IdType="pmc">PMC8502894</ArticleId><ArticleId IdType="pubmed">34646834</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla A, Abosalif K, Ahmed Z, Younas S. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833&#x2013;1839. doi: 10.1016/j.jiph.2020.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.07.014</ArticleId><ArticleId IdType="pmc">PMC7402107</ArticleId><ArticleId IdType="pubmed">32788073</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany, NY) 2020;12(7):6049&#x2013;6057. doi: 10.18632/aging.103000.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103000</ArticleId><ArticleId IdType="pmc">PMC7185114</ArticleId><ArticleId IdType="pubmed">32267833</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundstrom K, Hromi&#x107;-Jahjefendi&#x107; A, Bilajac E, Aljabali AAA, Barali&#x107; K, Sabri NA, Shehata EM, Raslan M, Ferreira A, Orlandi L, Serrano-Aroca &#xc1;, Tambuwala MM, Uversky VN, Azevedo V, Alzahrani KJ, Alsharif KF, Halawani IF, Alzahrani FM, Redwan EM, Barh D. COVID-19 signalome: Pathways for SARS-COV-2 infection and impact on COVID-19 associated comorbidity. Cell Signal. 2023;101:110495. doi: 10.1016/j.cellsig.2022.110495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2022.110495</ArticleId><ArticleId IdType="pmc">PMC9568271</ArticleId><ArticleId IdType="pubmed">36252792</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato K, Sakamoto K, Hashimoto Y, Hanzawa K, Sueta D, Kojima S, Fukuda M, Usuku H, Kihara F, Hosokawa H, Nagai Y, Nakajima M, Saito Y, Sakai K, Masunaga S, Tanaka S, Fujimoto K, Morihisa K, Noda K, Nishigami K, Nagata K, Fujisue K, Tabata N, Ando Y, Tsujita K, Ogawa H, Hokimoto S, on behalf of the KEEP Project Risk factors and prevalence of deep vein thrombosis after the 2016 Kumamoto earthquakes. Circ J. 2019;83(6):1342&#x2013;1348. doi: 10.1253/circj.CJ-18-1369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-18-1369</ArticleId><ArticleId IdType="pubmed">30956268</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow L, Chew L, Leong T, Mohamad Tazuddin E, Chua H. Thrombosis and bleeding as presentation of COVID-19 infection with polycythemia vera. A case report. SN Compr Clin Med. 2020;2(11):2406&#x2013;2410. doi: 10.1007/s42399-020-00537-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00537-0</ArticleId><ArticleId IdType="pmc">PMC7532949</ArticleId><ArticleId IdType="pubmed">33043250</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey M, Chatterjee S, Lahiri D, Lavie C. Psychosocial impact of COVID-19. Diabetes Metab Syndr. 2020;14(5):779&#x2013;788. doi: 10.1016/j.dsx.2020.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.05.035</ArticleId><ArticleId IdType="pmc">PMC7255207</ArticleId><ArticleId IdType="pubmed">32526627</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover S, Sahoo S, Mehra A, Avasthi A, Tripathi A, Subramanyan A, Pattojoshi A, Rao G, Saha G, Mishra K, Chakraborty K, Rao N, Vaishnav M, Singh O, Dalal P, Chadda R, Gupta R, Gautam S, Sarkar S, Sathyanarayana Rao T, Kumar V, Janardran Reddy Y. Psychological impact of COVID-19 lockdown: An online survey from India. Indian J Psychiatry. 2020;62(4):354. doi: 10.4103/psychiatry.IndianJPsychiatry_427_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/psychiatry.IndianJPsychiatry_427_20</ArticleId><ArticleId IdType="pmc">PMC7597717</ArticleId><ArticleId IdType="pubmed">33165368</ArticleId></ArticleIdList></Reference><Reference><Citation>Serafini G, Parmigiani B, Amerio A, Aguglia A, Sher L, Amore M. The psychological impact of COVID-19 on the mental health in the general population. QJM. 2020;113(8):531&#x2013;537. doi: 10.1093/qjmed/hcaa201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa201</ArticleId><ArticleId IdType="pmc">PMC7337855</ArticleId><ArticleId IdType="pubmed">32569360</ArticleId></ArticleIdList></Reference><Reference><Citation>Deolmi M, Pisani F. Psychological and psychiatric impact of COVID-19 pandemic among children and adolescents. Acta Bio Medica: Acta Biomed. 2020;91(4):e2020149. doi: 10.23750/abm.v91i4.10870.</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i4.10870</ArticleId><ArticleId IdType="pmc">PMC7927507</ArticleId><ArticleId IdType="pubmed">33525229</ArticleId></ArticleIdList></Reference><Reference><Citation>Mechanick J, Christofides E, Marchetti A, Hoddy K, Joachim J, Hegazi R, Hamdy O. The syndromic triad of COVID-19, type 2 diabetes, and malnutrition. Front Nutr. 2023;10:1122203. doi: 10.3389/fnut.2023.1122203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2023.1122203</ArticleId><ArticleId IdType="pmc">PMC9988958</ArticleId><ArticleId IdType="pubmed">36895277</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding J, Oviedo S, Ali M, Ofotokun I, Gander J, Patel S, Magliano D, Patzer R. The bidirectional association between diabetes and long-COVID-19 - A systematic review. Diabetes Res Clin Pract. 2023;195:110202. doi: 10.1016/j.diabres.2022.110202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2022.110202</ArticleId><ArticleId IdType="pmc">PMC9727969</ArticleId><ArticleId IdType="pubmed">36496030</ArticleId></ArticleIdList></Reference><Reference><Citation>Vosko I, Zirlik A, Bugger H. Impact of COVID-19 on cardiovascular disease. Viruses. 2023;15(2):508. doi: 10.3390/v15020508.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020508</ArticleId><ArticleId IdType="pmc">PMC9962056</ArticleId><ArticleId IdType="pubmed">36851722</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolu-Akinnawo O, Adusei Poku F, Elimihele T, League M, Adkins C, Okafor H. Acute cardiovascular complications of COVID-19: a systematic review. Cureus. 2023;15(5):e38576. doi: 10.7759/cureus.38576.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.38576</ArticleId><ArticleId IdType="pmc">PMC10166388</ArticleId><ArticleId IdType="pubmed">37168413</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobler D, Pruzansky A, Naderi S, Ambrosy A, Slade J. Long-term cardiovascular effects of COVID-19: Emerging data relevant to the cardiovascular clinician. Curr Atheroscler Rep. 2022;24(7):563&#x2013;570. doi: 10.1007/s11883-022-01032-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-022-01032-8</ArticleId><ArticleId IdType="pmc">PMC9065238</ArticleId><ArticleId IdType="pubmed">35507278</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizvi A, Kathuria A, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Galia M, Goh S, Janez A, Kalra S, Kempler P, Lessan N, Lotufo P, Papanas N, Santos R, Stoian A, Toth P, Viswanathan V, Rizzo M. Post-COVID syndrome, inflammation, and diabetes. J Diabetes Complications. 2022;36(11):108336. doi: 10.1016/j.jdiacomp.2022.108336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2022.108336</ArticleId><ArticleId IdType="pmc">PMC9534783</ArticleId><ArticleId IdType="pubmed">36228563</ArticleId></ArticleIdList></Reference><Reference><Citation>Spyropoulos A, Connors J, Douketis J, Goldin M, Hunt B, Kotila T, Lopes R, Schulman S. The international society on thrombosis and haemostasis: Good practice statements for antithrombotic therapy in the management of COVID 19 Guidance from the SSC of the ISTH. J Thromb Haemost. 2022;20(10):2226&#x2013;2236. doi: 10.1111/jth.15809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15809</ArticleId><ArticleId IdType="pmc">PMC9349985</ArticleId><ArticleId IdType="pubmed">35906715</ArticleId></ArticleIdList></Reference><Reference><Citation>Acanfora D, Ciccone M, Carlomagno V, Scicchitano P, Acanfora C, Bortone A, Uguccioni M, Casucci G. A systematic review of the efficacy and safety of direct oral anticoagulants in atrial fibrillation patients with diabetes using a risk index. J Clin Med. 2021;10(13):2924. doi: 10.3390/jcm10132924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132924</ArticleId><ArticleId IdType="pmc">PMC8268134</ArticleId><ArticleId IdType="pubmed">34210028</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>